Form 4 for BSX Boston Scientific
Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0001225208-22-002683 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-17 | 2022-02-15 | BSX | Olson Scott | SVP, Pres, CRM, Diagnostics | M - OptEx | $0.00 | +1,292 | 13.6K | +11% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Olson Scott | SVP, Pres, CRM, Diagnostics | F - Tax | $44.01 | -707 | 12.8K | -5% | -$31.1K |
| D | 2022-02-17 | 2022-02-15 | BSX | Olson Scott | SVP, Pres, CRM, Diagnostics | M - OptEx | $0.00 | -1,292 | 1,292 | -50% | $0 |
| DM | 2022-02-17 | 2022-02-16 | BSX | Olson Scott | SVP, Pres, CRM, Diagnostics | A - Grant | $0.00 | +20.7K | 5,374 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-15 | M | A | 1,292 | $0.00 | 13,551 | D | — | — | (F1) Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. (F2) Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. |
| 2 | Common | Common Stock | 2022-02-15 | F | D | 707 | $44.01 | 12,844 | D | — | — | |
| 3 | Derivative | Deferred Stock Units | 2022-02-15 | M | D | 1,292 | $0.00 | 1,292 | D | — · — to 2023-02-15 | 1,292 Common Stock | (F1) Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. (F3) Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant. |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-02-16 | A | A | 15,367 | $0.00 | 15,367 | D | $44.19 · — to 2032-02-16 | 15,367 Common Stock | (F6) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant. |
| 5 | Derivative | Restricted Stock Units | 2022-02-16 | A | A | 5,374 | $0.00 | 5,374 | D | — · — to 2026-02-16 | 5,374 Common Stock | (F4) Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. (F5) Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant. |